Mangaluru gets more rain than last year so far, but less than average

Mangaluru, Jan 23: Members of the Social Democratic Party of India (SDPI) on Thursday held a protest against the Karnataka government, accusing it of shielding Aditya Rao, the main accused of planting an improvised explosive device (IED) at the Mangaluru airport on January 20.

Meanwhile, the Judicial Magistrate First Class (JMFC) Court has sent the accused Aditya Rao to 10 days police custody.

Earlier on Wednesday, the Bengaluru Police said that the procedure is being followed to hand-over to the Mangaluru Police a suspect who surrendered before it two days after planting an improvised explosive device (IED) at the Mangaluru International Airport.

The IED was later defused in an open field by the personnel of the bomb disposal squad.

Mangaluru, Jan 8: The Muslim Central Committee of Dakshina Kannada and Udupi, has finally received green signal from the city police to hold an awareness meet against CAA, NRC and NPR on January 15, but on the outskirts of the city.

The Committee, which is a kind of umbrella body of Muslim organisations of the two coastal districts, had twice cancelled its planned protest against the same at Nehru Maidan, in the heart of the city due to permission denial by the city police. 

Addressing a press conference here today, Committee chairman, KS Mohammed Masood said that event will be held at Shaha Garden near Central Juma Masjid at Adyar Kannur.

He said that the representatives from the 28 different organisations unanimously finalised the date and venue after a consultations as the police refused to grant permission to hold the event at Nehru Maidan or Town Hall.

Representatives of various organisations including S M Rasheed Haji, Ibrahim Kodichal, B M Mumtaz Ali, Rafeeuddin Kudroli and Abdul Rasheed Zaini were present at the press meet.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.